Straumann Holding AG Shares Outstanding 2012-2024 | SAUHY

Straumann Holding AG shares outstanding history from 2012 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Straumann Holding AG shares outstanding for the quarter ending December 31, 2024 were 0M, a 0% increase year-over-year.
  • Straumann Holding AG 2024 shares outstanding were 1.596B, a 0.03% decline from 2023.
  • Straumann Holding AG 2023 shares outstanding were 1.596B, a 90% decline from 2022.
  • Straumann Holding AG 2022 shares outstanding were 15.957B, a 899.88% increase from 2021.
Straumann Holding AG Annual Shares Outstanding
(Millions of Shares)
2024 1,596
2023 1,596
2022 15,957
2021 1,596
2020 1,593
2019 1,591
2018 1,588
2017 1,557
2016 1,573
2015 1,583
2014 1,574
2013 1,545
2012 1,544
2011 0
Straumann Holding AG Quarterly Shares Outstanding
(Millions of Shares)
2024-12-31
2024-06-30
2023-12-31
2022-12-31
2021-12-31
2021-06-30
2020-12-31
2020-06-30
2019-12-31
2018-12-31
2017-12-31
2017-06-30
2016-12-31
2016-06-30
2015-12-31
2014-12-31
2013-12-31
2013-06-30
2012-12-31
2012-06-30
2011-12-31
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $20.570B $2.845B
The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $89.188B 21.54
Becton Dickinson (BDX) United States $49.818B 12.34
Cardinal Health (CAH) United States $36.754B 19.25
Labcorp (LH) United States $20.653B 16.75
Cooper (COO) United States $15.991B 20.61
West Pharmaceutical Services (WST) United States $15.121B 31.70
Align Technology (ALGN) United States $13.268B 26.34
Henry Schein (HSIC) United States $8.761B 15.03
Merit Medical Systems (MMSI) United States $5.604B 27.09
DENTSPLY SIRONA (XRAY) United States $3.254B 9.72
CONMED (CNMD) United States $1.785B 13.35
STAAR Surgical (STAA) United States $0.908B 0.00
Lifevantage (LFVN) United States $0.160B 16.49
Pro-Dex (PDEX) United States $0.132B 14.41